Search Results - "Radominski, Sebastião Cézar"
-
1
Brazilian guidelines for the diagnosis and treatment of postmenopausal osteoporosis
Published in Revista Brasileira de Reumatologia (2017)“…Osteoporosis is the leading cause of fractures in the population older than 50 years. This silent disease affects primarily postmenopausal women and the…”
Get full text
Journal Article -
2
Predictors of serious infections in rheumatoid arthritis-a prospective Brazilian cohort
Published in Advances in rheumatology (London, England) (29-03-2024)“…Infections increase mortality and morbidity and often limit immunosuppressive treatment in rheumatoid arthritis patients. To analyze the occurrence of serious…”
Get full text
Journal Article -
3
Real - rheumatoid arthritis in real life - study cohort: a sociodemographic profile of rheumatoid arthritis in Brazil
Published in Advances in rheumatology (London, England) (14-03-2020)“…In Brazil, socioeconomic differences in the incidence of rheumatoid arthritis (RA) have been demonstrated, which are important in the formulation of hypotheses…”
Get full text
Journal Article -
4
Rheumatoid artrhitis treatment in Brazil: data from a large real-life multicenter study
Published in Advances in rheumatology (London, England) (27-02-2020)“…Last decades witnessed great technological advances in rheumatoid arthritis (RA) management, but their implementation in clinical practice might prove…”
Get full text
Journal Article -
5
Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study
Published in PloS one (29-09-2022)“…Introduction Rheumatoid arthritis (RA) composite disease activity indices have become handy tools in daily clinical practice and crucial in defining remission…”
Get full text
Journal Article -
6
Extra-articular manifestations of rheumatoid arthritis remain a major challenge: data from a large, multi-centric cohort
Published in Advances in rheumatology (London, England) (26-07-2023)“…Although Rheumatoid Arthritis (RA) extra-articular manifestations (ExtRA) occurrence has been decreasing over time, they are still a major mortality risk…”
Get full text
Journal Article -
7
Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study
Published in Advances in rheumatology (London, England) (24-04-2023)“…Early rheumatoid arthritis (RA) offers an opportunity for better treatment outcomes. In real-life settings, grasping this opportunity might depend on access to…”
Get full text
Journal Article -
8
The REAL study: a nationwide prospective study of rheumatoid arthritis in Brazil
Published in Advances in rheumatology (London, England) (28-06-2018)“…There are few data on the epidemiology, clinical manifestations and management of RA in Brazil, even with the recognition of the high direct, indirect and…”
Get full text
Journal Article -
9
Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial
Published in Advances in rheumatology (London, England) (19-01-2021)“…To compare the efficacy and safety of a new formulation of a fixed dose combination of glucosamine sulfate (GS; 1500 mg) and bovine chondroitin sulfate (CS;…”
Get full text
Journal Article -
10
Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program
Published in Clinical rheumatology (01-05-2023)“…Introduction/objectives Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by ongoing inflammation and degradation of synovial joints. The…”
Get full text
Journal Article -
11
Performance of the Rheumatoid Arthritis Disease Activity Index in the Assessment of Disease Activity in Rheumatoid Arthritis—Findings From the REAL Study
Published in Journal of clinical rheumatology (01-06-2022)“…Although telemedicine use has been under discussion for decades, this topic has gained unprecedented importance during the COVID-19 pandemic. The Rheumatoid…”
Get full text
Journal Article -
12
Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs ‘in’ rheumatoid arthritis
Published in International journal of clinical pharmacy (01-06-2021)“…Background Rheumatoid arthritis is a chronic, autoimmune disease in which treatment has evolved with a variety of therapeutic classes. Biological…”
Get full text
Journal Article -
13
Evaluation of rheumatoid factor and anti-citrullinated peptide antibodies in relation to rheumatological manifestations in patients with leprosy from Southern Brazil
Published in International journal of rheumatic diseases (01-10-2016)“…Background Leprosy patients may present several osteoarticular complaints, which require further evaluation of inflammatory diseases, such as rheumatoid…”
Get full text
Journal Article -
14
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies
Published in Reumatologia clinica (01-07-2017)“…Abstract Objective Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). We assessed tofacitinib efficacy and safety in…”
Get full text
Journal Article -
15
Discordance between the patient's and physician's global assessment in rheumatoid arthritis: Data from the REAL study-Brazil
Published in PloS one (13-03-2020)“…Discordance between patient's global assessment (PtGA) and physician's global assessment (PhGA) has been described in rheumatoid arthritis (RA). Understanding…”
Get full text
Journal Article -
16
Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study
Published in PloS one (29-09-2022)“…Introduction Rheumatoid arthritis (RA) composite disease activity indices have become handy tools in daily clinical practice and crucial in defining remission…”
Get full text
Journal Article -
17
-
18
Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort
Published in PloS one (01-03-2019)“…The treatment of rheumatoid arthritis (RA) has evolved rapidly in recent years. Nonetheless, conventional synthetic disease-modifying drugs (csDMARDs) remain…”
Get full text
Journal Article -
19
Correction: Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort
Published in PloS one (04-04-2019)“…[This corrects the article DOI: 10.1371/journal.pone.0213219.]…”
Get full text
Journal Article -
20
Decreasing delays in the diagnosis and treatment of rheumatoid arthritis in Brazil: a nationwide multicenter observational study
Published in Advances in rheumatology (London, England) (06-02-2023)“…Management delays imply worse outcomes in rheumatoid arthritis (RA) and, therefore, should be minimized. We evaluated changes in diagnostic and treatment…”
Get full text
Journal Article